drugset / Trial / NCT01093326
Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is an extension to the study AC-058B201 and will investigate the long-term safety, tolerability and efficacy of ponesimod in patients with relapsing-remitting multiple sclerosis.
Timeline
- Start
- 2010-05-12
- Primary completion
- 2023-09-06
- Completion
- 2023-09-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ponesimod | Small molecule | 10 mg | Oral |
| Subject | Ponesimod | Small molecule | 20 mg | Oral |
| Subject | Ponesimod | Small molecule | 40 mg | Oral |